They are sold as dietary supplements, which means they are not reviewed for safety, effectiveness, or quality the same way prescription GLP-1 treatments are
also, WES was found to increase GLP-1 secretion in vivo [18]
10.1136/gutjnl-2017-315193 Summary Keywords carnitine, non-alcoholic fatty liver disease, L-carnitine supplementation, targeted therapy, therapeutic diet Citation Li N and Zhao H (2021) Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
This approach prevents prolonged periods without protein consumption while avoiding competition with main meals
People with type 2 diabetes taking metformin may already have reduced vitamin B12 levels, which could be a confounding factor
Are your patients taking or asking you about the new GLP-1RA weight loss medications (Semaglutide, Ozempic, Wegovy, Tirzepatide, Mounjaro, Zepbound)